Item 2.02. Results of Operations and Financial Condition.

On March 15, 2021, PURE Bioscience, Inc. (the "Company") issued a press release announcing financial results for the fiscal quarter ended January 31, 2021 and related information. A copy of the press release is attached as Exhibit 99.1.

The information in this Item 2.02 is being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that Section. The information in this Item 2.02 shall not be incorporated by reference into any registration statement or other document filed with the Securities and Exchange Commission.

Item 9.01. Financial Statements and Exhibits.





(d) Exhibits



  99.1     Press Release, dated March 15, 2021.

* Exhibit 99.1 is being furnished and shall not be deemed "filed" for the

purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise

subject to the liabilities of that Section, nor shall it be incorporated by

reference into any registration statement or other document filed with the

Securities and Exchange Commission.

© Edgar Online, source Glimpses